Published in Eur J Biochem on March 15, 1984
Interaction between fibrinogen and cultured endothelial cells. Induction of migration and specific binding. J Clin Invest (1985) 1.79
Fibroblast migration in fibrin gel matrices. Am J Pathol (1993) 1.64
Immunologic relationship between platelet membrane glycoprotein GPIIb/IIIa and cell surface molecules expressed by a variety of cells. Proc Natl Acad Sci U S A (1986) 1.48
Fibrin induces release of von Willebrand factor from endothelial cells. J Clin Invest (1987) 1.22
Specific binding of human fibrinogen fragment D to Aspergillus fumigatus conidia. Infect Immun (1992) 1.12
Increased plasminogen activator inhibitor-1 in keloid fibroblasts may account for their elevated collagen accumulation in fibrin gel cultures. Am J Pathol (2003) 0.90
Fibrin-induced skin fibrosis in mice deficient in tissue plasminogen activator. Am J Pathol (2005) 0.89
Modulation of polymorphonuclear leukocyte microbicidal activity and oxidative metabolism by fibrinogen degradation products D and E. J Clin Invest (1989) 0.87
Generation of forms of fragment E with differing thrombin-binding properties during digestion of fibrinogen by plasmin. Biochem J (1992) 0.75
Targeted deficiency or cytosolic truncation of the VE-cadherin gene in mice impairs VEGF-mediated endothelial survival and angiogenesis. Cell (1999) 7.33
Junctional adhesion molecule, a novel member of the immunoglobulin superfamily that distributes at intercellular junctions and modulates monocyte transmigration. J Cell Biol (1998) 5.32
Human cytotrophoblasts adopt a vascular phenotype as they differentiate. A strategy for successful endovascular invasion? J Clin Invest (1997) 3.93
A novel endothelial-specific membrane protein is a marker of cell-cell contacts. J Cell Biol (1992) 3.85
Vascular endothelial growth factor induces VE-cadherin tyrosine phosphorylation in endothelial cells. J Cell Sci (1998) 3.80
Vascular endothelial-cadherin is an important determinant of microvascular integrity in vivo. Proc Natl Acad Sci U S A (1999) 3.49
Cultured human endothelial cells generate tissue factor in response to endotoxin. J Clin Invest (1983) 3.47
Megakaryocytic and erythrocytic lineages share specific transcription factors. Nature (1990) 3.42
The molecular organization of endothelial cell to cell junctions: differential association of plakoglobin, beta-catenin, and alpha-catenin with vascular endothelial cadherin (VE-cadherin). J Cell Biol (1995) 3.27
Haemolytic-uraemic syndrome: deficiency of plasma factor(s) regulating prostacyclin activity? Lancet (1978) 3.15
Cytokine regulation of endothelial cell function. FASEB J (1992) 3.00
Embryonic stem cells differentiate in vitro to endothelial cells through successive maturation steps. Blood (1996) 2.94
IL-1 stimulates IL-6 production in endothelial cells. J Immunol (1989) 2.85
Molecular cloning and expression of murine vascular endothelial-cadherin in early stage development of cardiovascular system. Blood (1996) 2.76
Inhibition of anchorage-dependent cell spreading triggers apoptosis in cultured human endothelial cells. J Cell Biol (1994) 2.63
Cytokines as communication signals between leukocytes and endothelial cells. Immunol Today (1989) 2.60
Catenin-dependent and -independent functions of vascular endothelial cadherin. J Biol Chem (1995) 2.40
Functional properties of human vascular endothelial cadherin (7B4/cadherin-5), an endothelium-specific cadherin. Arterioscler Thromb Vasc Biol (1995) 2.25
Long-term evaluation of HIV antigen and antibodies to p24 and gp41 in patients with hemophilia. Potential clinical importance. N Engl J Med (1987) 2.18
Interaction of junctional adhesion molecule with the tight junction components ZO-1, cingulin, and occludin. J Biol Chem (2000) 2.13
Prostacyclin synthesis induced in vascular cells by interleukin-1. Science (1985) 2.13
Monocyte chemotactic and activating factor gene expression induced in endothelial cells by IL-1 and tumor necrosis factor. J Immunol (1990) 2.10
Differential localization of VE- and N-cadherins in human endothelial cells: VE-cadherin competes with N-cadherin for junctional localization. J Cell Biol (1998) 2.08
Polymorphisms of the interleukin-1beta gene affect the risk of myocardial infarction and ischemic stroke at young age and the response of mononuclear cells to stimulation in vitro. Arterioscler Thromb Vasc Biol (2004) 2.02
Cell confluence regulates tyrosine phosphorylation of adherens junction components in endothelial cells. J Cell Sci (1997) 2.01
Regulation of the VLA integrin-ligand interactions through the beta 1 subunit. J Cell Biol (1992) 1.96
Regulation of cadherin function by Rho and Rac: modulation by junction maturation and cellular context. Mol Biol Cell (1999) 1.94
Heterogeneity of endothelial cells. Specific markers. Arterioscler Thromb Vasc Biol (1997) 1.94
Adriamycin-induced nephrotic syndrome in rats: sequence of pathologic events. Lab Invest (1982) 1.90
Polymorphonuclear leukocyte adhesion triggers the disorganization of endothelial cell-to-cell adherens junctions. J Cell Biol (1996) 1.90
In vivo anti-inflammatory effect of statins is mediated by nonsterol mevalonate products. Arterioscler Thromb Vasc Biol (2001) 1.88
The role of integrins in the maintenance of endothelial monolayer integrity. J Cell Biol (1991) 1.85
Targeted null-mutation in the vascular endothelial-cadherin gene impairs the organization of vascular-like structures in embryoid bodies. Proc Natl Acad Sci U S A (1997) 1.84
Evidence that three adhesive proteins interact with a common recognition site on activated platelets. J Biol Chem (1984) 1.83
Inhibition of fibronectin binding to platelets by proteolytic fragments and synthetic peptides which support fibroblast adhesion. J Biol Chem (1985) 1.81
Histamine induces tyrosine phosphorylation of endothelial cell-to-cell adherens junctions. Arterioscler Thromb Vasc Biol (1999) 1.81
Cardiomyocytes induce endothelial cells to trans-differentiate into cardiac muscle: implications for myocardium regeneration. Proc Natl Acad Sci U S A (2001) 1.81
Interaction between fibrinogen and cultured endothelial cells. Induction of migration and specific binding. J Clin Invest (1985) 1.79
Thrombin-induced increase in endothelial permeability is associated with changes in cell-to-cell junction organization. Arterioscler Thromb Vasc Biol (1996) 1.78
Interleukin 1-induced augmentation of experimental metastases from a human melanoma in nude mice. Cancer Res (1990) 1.77
X-ray structure of junctional adhesion molecule: structural basis for homophilic adhesion via a novel dimerization motif. EMBO J (2001) 1.75
Effect of heparin, dermatan sulfate, and related oligo-derivatives on human polymorphonuclear leukocyte functions. J Lab Clin Med (1993) 1.72
Spatial and temporal relationships between cadherins and PECAM-1 in cell-cell junctions of human endothelial cells. J Cell Biol (1994) 1.70
Leukocyte recruitment in the cerebrospinal fluid of mice with experimental meningitis is inhibited by an antibody to junctional adhesion molecule (JAM). J Exp Med (1999) 1.68
Platelet membrane glycoproteins implicated in ristocetin-induced aggregation. Studies of the proteins on platelets from patients with Bernard-Soulier syndrome and von Willebrand's disease. J Clin Invest (1976) 1.67
Fibrinogen induces adhesion, spreading, and microfilament organization of human endothelial cells in vitro. J Cell Biol (1987) 1.59
Interleukin 1 stimulates platelet-activating factor production in cultured human endothelial cells. J Clin Invest (1986) 1.57
Development of endothelial cell lines from embryonic stem cells: A tool for studying genetically manipulated endothelial cells in vitro. Arterioscler Thromb Vasc Biol (2000) 1.57
Molecules and structures involved in the adhesion of natural killer cells to vascular endothelium. J Exp Med (1991) 1.51
Evidence that vascular endothelial cells can induce the retraction of fibrin clots. Proc Soc Exp Biol Med (1981) 1.51
Inhibition of cultured cell growth by vascular endothelial cadherin (cadherin-5/VE-cadherin). J Clin Invest (1996) 1.49
IL-1 transcriptionally activates the neutrophil chemotactic factor/IL-8 gene in endothelial cells. Immunology (1990) 1.47
Interendothelial junctions: structure, signalling and functional roles. Curr Opin Cell Biol (1997) 1.46
The vascular endothelial-cadherin promoter directs endothelial-specific expression in transgenic mice. Blood (1999) 1.45
CD34 expression is regulated reciprocally with adhesion molecules in vascular endothelial cells in vitro. Blood (1993) 1.44
Prostacyclin and human foetal circulation. Prostaglandins (1979) 1.42
Homocysteine levels are associated with the severity of peripheral arterial disease in Type 2 diabetic patients. J Thromb Haemost (2003) 1.42
Cancer cell procoagulant activity: evaluation by an amidolytic assay. Thromb Res (1980) 1.41
Evidence that arginyl-glycyl-aspartate peptides and fibrinogen gamma chain peptides share a common binding site on platelets. J Biol Chem (1987) 1.41
Modulation of vitronectin receptor binding by membrane lipid composition. J Biol Chem (1990) 1.38
Homophilic interaction of junctional adhesion molecule. J Biol Chem (2000) 1.37
Molecules involved in the adhesion and cytotoxicity of activated monocytes on endothelial cells. J Immunol (1992) 1.36
Divalent cation regulation of the surface orientation of platelet membrane glycoprotein IIb. Correlation with fibrinogen binding function and definition of a novel variant of Glanzmann's thrombasthenia. J Clin Invest (1986) 1.35
Reduced umbilical and placental vascular prostacyclin in severe pre-eclampsia. Prostaglandins (1980) 1.33
Human polymorphonuclear leukocytes produce and express functional tissue factor upon stimulation. J Thromb Haemost (2006) 1.30
Willebrand factor and ristocetin. I. Mechanism of rustocetin-induced platelet aggregation. Br J Haematol (1974) 1.29
Identification and characterisation of human Junctional Adhesion Molecule (JAM). Mol Immunol (1999) 1.29
Monoclonal antibody to vascular endothelial-cadherin is a potent inhibitor of angiogenesis, tumor growth, and metastasis. Cancer Res (2000) 1.27
Bleeding time in laboratory animals. II - A comparison of different assay conditions in rats. Thromb Res (1979) 1.26
Ser968Thr mutation within the A3 domain of von Willebrand factor (VWF) in two related patients leads to a defective binding of VWF to collagen. Thromb Haemost (2001) 1.25
Association of junctional adhesion molecule with calcium/calmodulin-dependent serine protein kinase (CASK/LIN-2) in human epithelial caco-2 cells. J Biol Chem (2000) 1.21
Relation of the -174 G/C polymorphism of interleukin-6 to interleukin-6 plasma levels and to length of hospitalization after surgical coronary revascularization. Am J Cardiol (2001) 1.21
Arginyl-glycyl-aspartic acid sequences and fibrinogen binding to platelets. Blood (1987) 1.20
Availability of platelet Factor 3 and activation of factor XII in thrombasthenia. Nature (1965) 1.20
Co-expression of endothelial cell and macrophage antigens in Kaposi's sarcoma cells. J Pathol (1994) 1.19
Pathogenesis of thrombosis in patients with malignancy. Int J Hematol (2001) 1.18
A genetic nomenclature for human blood coagulation. Thromb Diath Haemorrh (1973) 1.18
Interaction of fibronectin with cultured human endothelial cells: characterization of the specific receptor. Blood (1989) 1.18
Human endothelial cells express integrin receptors on the luminal aspect of their membrane. Blood (1992) 1.17
Direct induction of tissue factor synthesis by endotoxin in human macrophages from diverse anatomical sites. Immunology (1983) 1.15
Dietary patterns, cardiovascular risk factors and C-reactive protein in a healthy Italian population. Nutr Metab Cardiovasc Dis (2009) 1.15
VE-cadherin and desmoplakin are assembled into dermal microvascular endothelial intercellular junctions: a pivotal role for plakoglobin in the recruitment of desmoplakin to intercellular junctions. J Cell Sci (1998) 1.15
Platelet hyperaggregability and the nephrotic syndrome. Thromb Res (1979) 1.12
Endothelial adhesion molecules in the development of the vascular tree: the garden of forking paths. Curr Opin Cell Biol (1999) 1.11
Tumor cell adhesion to endothelial cells: endothelial leukocyte adhesion molecule-1 as an inducible adhesive receptor specific for colon carcinoma cells. J Natl Cancer Inst (1991) 1.11
Tissue-specific expression of the platelet GPIIb gene. J Biol Chem (1991) 1.10
Generation of procoagulant activity by mononuclear phagocytes: a possible mechanism contributing to blood clotting activation within malignant tissues. Blood (1983) 1.10
Inhibition of platelet endothelial cell adhesion molecule-1 synthesis and leukocyte transmigration in endothelial cells by the combined action of TNF-alpha and IFN-gamma. J Immunol (1996) 1.09